Summary
PHARMARIVE has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €114,888 and a net result of -€19,028. Equity is shrinking by about 6.9% per year across the filed financial years. Its solvency ranks better than 18% of 12,737 sector peers (NACE 47, financial year 2025). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 22002B0093/00E000 | Flanders | 1,774 m² | 1 · 217 m² | 19.4 m · 5 |
| 21005A0506/00T003 | Brussels | 93 m² | 1 · 85 m² | 15.0 m · 4 |